Prescription insurance managed by Express Scripts may not be covered. We accept most other plans. It's open enrollment - contact us to confirm eligibility.
GLP-1 Medications May Increase the Risk of Severe Acid Reflux
A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.
Health News is provided as a service to Pharmana Pharmacy site users by HealthDay. Pharmana Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.